The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities

被引:14
|
作者
Hoffman, Jodi D. [1 ]
Park, Jessica J. [2 ]
Schreiber-Agus, Nicole [3 ]
Kornreich, Ruth [4 ]
Tanner, Alice K. [5 ]
Keiles, Steven [6 ]
Friedman, Kenneth J. [7 ]
Heim, Ruth A. [8 ]
机构
[1] Floating Hosp Children, Div Genet, Tufts Med Ctr, Boston, MA 02116 USA
[2] Tufts Univ Sch Med, Sch Med, Boston, MA USA
[3] Albert Einstein Coll Med, Program Jewish Genet Hlth, Bronx, NY 10467 USA
[4] Icahn Sch Med Mt Sinai, Mt Sinai Genet Testing Lab, New York, NY 10029 USA
[5] Emory Univ, Emory Genet Lab, Decatur, GA USA
[6] Ambry Genet, Aliso Viejo, CA USA
[7] Lab Corp Amer Holdings, Res Triangle Pk, NC USA
[8] Lab Corp Amer Holdings, Integrated Genet, Westborough, MA USA
关键词
PRENATAL-DIAGNOSIS; POPULATION; GENE;
D O I
10.1002/pd.4446
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectiveAlthough prenatal/preconception carrier screening recommendations for individuals of Ashkenazi Jewish descent (AJ) were published by American College of Medical Genetics and Genomics (2008) and American College of Obstetrics and Gynecology (2009), scientific advances have led to widely varied screening panels. Mutation carrier frequencies are sometimes based on small, homogeneous AJ populations. This study sought to update the state of AJ screening for the obstetrician by assessing laboratory screening panel compositions as well as assessing literature and laboratory carrier frequencies for common AJ mutations. MethodsA literature review (1991-2013) was performed for AJ disease carrier frequencies. AJ screening data from six screening laboratories were collected. AJ panel composition was compared across 16 commercial and academic laboratories. ResultsOverall literature and laboratory carrier frequencies of AJ mutations were similar, although the Walker-Warburg syndrome laboratory carrier frequency was almost twice that in the literature. Laboratory AJ disease panel composition varied widely, from 8 to 25 diseases. ConclusionsCurrent AJ panels vary widely by laboratory, resulting in disparate levels of screening. Consideration of an updated professional standard for prenatal/preconception AJ screening based on carrier frequency rates, level of disease burden, availability of screening, and cost of technology may be useful in providing equitable and appropriate care for those planning a pregnancy. (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:1161 / 1167
页数:7
相关论文
共 50 条
  • [41] Status quo HüftdysplasiescreeningStatus quo of screening for hip dysplasia
    T. Seidl
    C. Chiari
    Die Orthopädie, 2022, 51 : 853 - 862
  • [42] Ashkenazi carrier screening for reproductive planning: is this what we planned for?
    Zlotogora, Joel
    Meiner, Vardiella
    GENETICS IN MEDICINE, 2016, 18 (05) : 529 - 529
  • [43] Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze
    Ferreira, Jose Carlos P.
    Schreiber-Agus, Nicole
    Carter, Suzanne M.
    Klugman, Susan
    Gregg, Anthony R.
    Gross, Susan J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (03) : 197 - 204
  • [44] Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals
    Reed-Weston, Anne E.
    Espinal, Aileen
    Hasar, Bianca
    Chiuzan, Codruta
    Lazarin, Gabriel
    Weng, Chunhua
    Appelbaum, Paul S.
    Chung, Wendy K.
    Wynn, Julia
    JOURNAL OF COMMUNITY GENETICS, 2020, 11 (04) : 391 - 403
  • [45] Premarital and prenatal screening for cystic fibrosis: Experience in the Ashkenazi Jewish population
    Kornreich, R
    Ekstein, J
    Edelmann, L
    Desnick, RJ
    GENETICS IN MEDICINE, 2004, 6 (05) : 415 - 420
  • [46] Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals
    Anne E. Reed-Weston
    Aileen Espinal
    Bianca Hasar
    Codruta Chiuzan
    Gabriel Lazarin
    Chunhua Weng
    Paul S. Appelbaum
    Wendy K. Chung
    Julia Wynn
    Journal of Community Genetics, 2020, 11 : 391 - 403
  • [47] Mucolipidosis type IV a rare genetic disorder: New addition to the Ashkenazi Jewish Panel
    Gordon, RM
    Marchese, T
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2004, 49 (04) : 359 - 360
  • [48] Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
    Melanie W. Hardy
    Beth N. Peshkin
    Esther Rose
    Mary Kathleen Ladd
    Savannah Binion
    Mara Tynan
    Colleen M. McBride
    Karen A. Grinzaid
    Marc D. Schwartz
    Journal of Community Genetics, 2022, 13 : 281 - 292
  • [49] Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
    Hardy, Melanie W.
    Peshkin, Beth N.
    Rose, Esther
    Ladd, Mary Kathleen
    Binion, Savannah
    Tynan, Mara
    McBride, Colleen M.
    Grinzaid, Karen A.
    Schwartz, Marc D.
    JOURNAL OF COMMUNITY GENETICS, 2022, 13 (03) : 281 - 292
  • [50] Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin
    Kadir, R. A.
    Kingman, C. E. C.
    Chi, C.
    O'Connell, N. M.
    Riddell, A.
    Lee, C. A.
    Economides, D. L.
    HAEMOPHILIA, 2006, 12 (06) : 625 - 628